Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3. | Clin Transl Med | 2022 | 35678231 | PubTator, text mining | PubMed |
| Silencing PLOD2 attenuates cancer stem cell-like characteristics and cisplatin-resistant through Integrin β1 in laryngeal cancer. | Transl Oncol | 2022 | 35660870 | PubTator, text mining | PubMed |
| Ligand-Binding Sites in Vanilloid-Subtype TRP Channels. | Front Pharmacol | 2022 | 35652046 | PubTator, text mining | PubMed |
| Clinical characteristics and social determinants of health associated with 30-day hospital readmissions of patients with COVID-19. | J Investig Med | 2022 | 35649686 | PubTator, text mining | PubMed |
| Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35646104 | PubTator, text mining | PubMed |
| PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma. | Genes (Basel) | 2022 | 35627171 | PubTator, text mining | PubMed |
| Signaling Pathways Regulating the Expression of the Glioblastoma Invasion Factor TENM1. | Biomedicines | 2022 | 35625843 | PubTator, text mining | PubMed |
| Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response. | Biomedicines | 2022 | 35625760 | PubTator, text mining | PubMed |
| Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy. | Biomolecules | 2022 | 35625629 | PubTator, text mining | PubMed |
| The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis. | Biomolecules | 2022 | 35625561 | PubTator, text mining | PubMed |
| Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma. | BMC Neurol | 2022 | 35614390 | PubTator, text mining | PubMed |
| Genetic Analysis and Functional Study of a Pedigree With Bruck Syndrome Caused by PLOD2 Variant. | Front Pediatr | 2022 | 35601416 | Swiss-Prot, curated | PubMed |
| Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2. | Front Genet | 2022 | 35586565 | PubTator, text mining | PubMed |
| Comprehensive Analysis of mTORC1 Signaling Pathway-Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy. | Front Mol Biosci | 2022 | 35573741 | PubTator, text mining | PubMed |
| Polymerizable Skin Hydrogel for Full Thickness Wound Healing. | Int J Mol Sci | 2022 | 35563225 | PubTator, text mining | PubMed |
| A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma. | Cancer Med | 2022 | 35560794 | PubTator, text mining | PubMed |
| Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis. | Front Pharmacol | 2022 | 35559258 | PubTator, text mining | PubMed |
| Prevalence and Hospital Admissions in Patients With Osteogenesis Imperfecta in The Netherlands: A Nationwide Registry Study. | Front Endocrinol (Lausanne) | 2022 | 35546999 | PubTator, text mining | PubMed |
| A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients. | J Clin Transl Hepatol | 2022 | 35528976 | PubTator, text mining | PubMed |
| CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells. | J Cancer | 2022 | 35517414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=21